Facebook Instagram Pinterest Reddit Tumblr X Youtube
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
PsyNews.com
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Home Featured Page 265

Featured

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

March 2026 Psychedelic Bill Round-up

Ketamine-Assisted Couple Therapy Training by Enamory

Quarterly Briefing: Q1 2026

Serotonin, Synapses, and Setting: Gitte Moos Knudsen on the Neurobiology of Psychedelic Action

The Psychedelic Writers Guild’s Denver Mixer

PTSF59 – Bipolar and Psychedelics, with Benjamin Mudge

MindMed Announces Appointment of Dr. Sarah Y. Vinson as Additional Director

Routes of Administration in Psychedelic Drug Research

COMPASS Pathways plc announces financial results and business highlights for the...

PharmaDrug Enters into Employment Agreement with Dr. Paul Van Slyke and...

The World Boxing Council and Wesana Health Announce Multi-Year Joint Efforts...

Silo Pharma announces important milestone. Investigator led study using Psilocybin to...

Numinus Wellness Announces Key Leadership Hires to Support Rapid Growth and...

MindMed Bolsters Management Team, Appoints Peter Mack PhD as Vice President...

Silo Wellness Partners with Kaivalya Kollectiv to Include 5-MeO-DMT In Psychedelic...

Load more

EDITOR PICKS

March 2026 Psychedelic Bill Round-up

Ketamine-Assisted Couple Therapy Training by Enamory

Quarterly Briefing: Q1 2026

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

    ABOUT US
    PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.
    FOLLOW US
    Facebook Instagram Pinterest Reddit Tumblr X Youtube
    ©